Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.45 |
| ▸ | CA3 | P07451 | 2/20 | 0.45 |
| ▸ | CA4 | P22748 | 2/20 | 0.45 |
| ▸ | CA6 | P23280 | 2/20 | 0.45 |
| ▸ | CA5A | P35218 | 2/20 | 0.45 |
| ▸ | CA7 | P43166 | 2/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.45 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.45 |
| ▸ | ANPEP | P15144 | 1/20 | 0.44 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.44 |
| ▸ | SRD5A2 | P31213 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28976969 | 0.84 | ALDH1A1 (0.55) | ALDH1A1TP53TSHRCA12CA1 | |
| SCHEMBL5805280 | 0.82 | ALDH1A1 (0.52) | ALDH1A1TP53TSHRCA12CA1 | |
| SCHEMBL9506114 | 0.82 | MAOB (0.62) | ALDH1A1TP53TSHRCA1CA2 | |
| SCHEMBL5576096 | 0.82 | ALDH1A1 (0.52) | ALDH1A1TP53TSHRCA12CA1 | |
| SCHEMBL5020596 | 0.82 | MAOB (0.62) | ALDH1A1TP53TSHRCA1CA2 | |
| SCHEMBL10639379 | 0.81 | NAPRT (0.57) | ALDH1A1TP53TSHRCA1CA2 | |
| SCHEMBL10639390 | 0.81 | NAPRT (0.57) | ALDH1A1TP53TSHRCA1CA2 | |
| SCHEMBL845691 | 0.80 | CA2 (0.52) | ALDH1A1TSHRCA2ANPEPENPEP | |
| SCHEMBL5576686 | 0.80 | ALDH1A1 (0.50) | ALDH1A1TP53TSHRCA12CA1 | |
| SCHEMBL8917566 | 0.80 | ALDH1A1 (0.50) | ALDH1A1TP53TSHRCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1906938-B1 | PHARMACEUTICAL FORMULATION OF NITROOXYDERIVATIVES OF NSAIDS | NICOX SA (FR) | 2010-10-20 | — | — | EP | disclosed |
| US-20090203759-A1 | PHARMACEUTICAL FORMULATION OF NITROOXYDERIVATIVES OF NSAIDS | NICOX SA (FR) | 2009-08-13 | — | — | US | disclosed |
| EP-1906938-A2 | PHARMACEUTICAL FORMULATION OF NITROOXYDERIVATIVES OF NSAIDS | NicOx SA (FR) | 2008-04-09 | — | — | EP | disclosed |
| WO-2007012539-A2 | PHARMACEUTICAL FORMULATION OF NITROOXYDERIVATIVES OF NSAIDS | NICOX S.A. (FR) | 2007-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203759-A1 | PHARMACEUTICAL FORMULATION OF NITROOXYDERIVATIVES OF NSAIDS | FASN, PTGS1, NOS2 | ALDH1A1 230/4885TP53 2389/4885TSHR 2805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.